Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients
Devayani Machiraju, Melanie Wiecken, Nina Lang, Ingrid Hülsmeyer, Jasmin Roth, Timo E. Schank, R Eurich, Niels Halama, Alexander Enk, Jessica C. Hassel
Abstract
= .07). Different soluble immune checkpoints characterized checkpoint inhibitor-resistant melanoma. Measuring these serum markers may have the potential to be used in clinical routine.
Topics & Concepts
ImmunotherapyMelanomaImmune systemMedicineImmunologyPD-L1Cancer researchImmune checkpointCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmunotherapy and Immune Responses